Leadership Demonstrates Confidence with Major IperionX Share Purchases

CEO & directors buy shares worth $2.65M, signaling strong internal confidence as IperionX aggressively scales titanium production capacity and advances its Tennessee rare earths project.

Senior executives at IperionX have made a significant collective investment in the company's equity, signaling strong internal confidence. On March 27, 2026, CEO Anastasios Arima and other directors purchased shares worth approximately $2.65 million in total. These transactions were executed on the open market at prevailing prices, with no discounts applied.

Details of the Executive Buys

The largest purchase was made by CEO Anastasios Arima, who acquired both common stock and American Depositary Shares (ADS) for a total investment of about $1.79 million. Director Todd Hannigan committed nearly $500,000, while fellow executives R. Tony Tripeny and Toby Symonds bought ADS valued at roughly $100,000 and $263,000, respectively.

Strategic Growth and Current Financial Posture

This vote of confidence coincides with an aggressive expansion strategy centered on titanium production. The company's Virginia facility currently has an annual capacity of 200 tons of titanium powder. Near-term plans aim to increase this output to 1,400 tons, with a long-term target of over 10,000 tons of high-performance titanium components annually by 2030. To support this growth, new equipment—including cold isostatic presses and sintering furnaces—is scheduled for delivery within 2026.

Concurrently, IperionX is advancing its titanium project in Tennessee. A definitive feasibility study for this initiative is expected in the second quarter of 2026. Notably, the project is designed to supply critical rare earth elements, such as dysprosium and terbium, for which the U.S. Department of Defense has already allocated grant funding.

Despite these strategic moves, the company is not yet profitable. Analysts covering the firm forecast a loss per share of $0.08 for the current fiscal year. However, its balance sheet remains robust, featuring a current ratio of 4.03 and minimal debt. The insider buying activity occurs at a share price substantially below the 52-week high of €5.02 reached in January 2026, representing a notably lower valuation entry point for the leadership team.